Bartl, Thomas
Paspalj, Valentina
Grimm, Christoph
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 24 February 2020
Accepted: 31 March 2020
First Online: 21 April 2020
Conflict of interest
: C. Grimm received consultant fees from AstraZeneca, Celgene, MSD, PharmaMar, Roche, GSK/Tesaro, Vifor Pharma and Clovis, compensation for lecturing activities from Amgen, AstraZeneca, MSD, PharmaMar, Roche, GSK/Tesaro and direct research funding: Meda Pharma, Roche Diagnostics. The disclosed funding is not related to the research reported. T. Bartl and V. Paspalj declare that they have no competing interests.